PubMed Hsieh MJ, Liu HT, Wang CN, Huang HY, Lin Y, et al
Published data from cagrilintide research specifically demonstrates reductions in relative fat mass while maintaining relative lean mass
Originally studied in humans and small animals, BPC-157 is now making waves in equine medicineespecially for horses recovering from tendon injuries, gastric issues, and soft tissue damage
It is the subject of ongoing experimental and preclinical research investigating its chemical properties, receptor interactions, and role in neuronal signalling pathways
Additionally, the results reported that when administering BPC 157 in concentrations of 0.5 ug/mL, growth hormone expression in the tendon fibroblasts was induced in a time-dependent manner from day 1 to day 3